Erasca, Inc. ( ERAS) - Stock Earnings
ERAS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -30.6 million USD | — USD |
| 2025Q4 | -29.1 million USD | — USD |
| 2026Q1 | -183.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ERAS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -125.0 million USD | — USD |
| 2024 | -161.7 million USD | — USD |
| 2025 | -124.5 million USD | — USD |
| 2026 Est. | — | — |
ERAS
Price: $14.43
52 week price:
Earnings Per Share: -0.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 393750
Market Capitalization: 4.2 billion